Navigation Links
Aflac CEO Funds Breast Cancer Symposium in Honor of Company's African-American Female Employees
Date:5/7/2008

Dan and Kathelen Amos Donate $50,000 to Emory Winship Cancer Institute

ATLANTA, May 7 /PRNewswire/ -- Dan and Kathelen Amos today announced a personal commitment of $50,000 to the Emory Winship Cancer Institute to host the first scientific symposium in the southeast focused on triple-negative breast cancer research. Dan Amos, Aflac chairman and CEO and Kathelen Amos, Aflac Foundation president, made the personal donation in honor of the company's African-American female employees who make up nearly 30 percent of the workforce. The symposium will be held on May 16 beginning at 7 a.m. at the Grand Hyatt in Atlanta.

"After being made aware of the disproportionate impact of this disease on young African American women, Dan and I immediately felt led to become involved," said Kathelen Amos. "This is highly personal for us, not solely out of professional regard for the key roles African American women play in the leadership at Aflac, but also out of a heightened concern for those we hold dear."

The inaugural Jean Sindab Triple-Negative Breast Cancer Symposium is designed to update oncologists and other healthcare professionals on the most current advances in triple-negative breast cancer, a fast-moving disease that is resistant to new targeted therapies and strikes African-American women more often than white women. In a recent population study, Emory researchers found that almost 47 percent of breast cancers in African-American women under the age of 55 were triple-negative.

"We are immensely grateful for Kathelen and Dan Amos' support, which allows Emory Winship Cancer Institute to bring together the nation's top researchers focused on triple-negative breast cancer," said Brian Leyland- Jones, MD, PhD, Executive Director of Emory Winship. "Kathelen and Dan Amos are among only a handful of private philanthropists in the nation who recognize the need for focused attention on this lesser known form of breast cancer."

The symposium w
'/>"/>

SOURCE Aflac Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Aflac Shareholders Have Their Say-on-Pay,
2. Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend
3. Aflac Incorporated To Release First Quarter Results on April 23, 2008
4. Aflac Named Among the 50 Best Companies for Supplier Diversity
5. Aflac Reaches $40 Million Milestone in Donations to the Aflac Cancer Center and Blood Disorders Service of Childrens Healthcare of Atlanta
6. Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference
7. Training Magazine Applauds Aflacs Employee Learning Programs
8. Aflac Incorporated Announces Fourth Quarter Results
9. Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
10. Aflac to Sponsor Iron Girl
11. Aflac Incorporated to Present at the Goldman Sachs Financial Services CEO Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... as evolutionary changes in a living organismhad been thought ... genome. , However, recent studies have shown that cancer ... arise simultaneously and in close proximity to each other. ... regions where chromosomal rearrangements take place. , The discovery, ... one day lead to new cancer therapies, according to ...
(Date:7/30/2014)... News) -- Some obese people have a genetic mutation ... their brains when they see food, researchers report. ... feelings of pleasure and gratification at the sight of ... to prevent overeating, the scientists suggested. More than ... typically caused by a combination of overeating, a lack ...
(Date:7/30/2014)... Georgia (PRWEB) July 30, 2014 The ... and Technology Alliance of TAG (B&TA), today issued its ... TAG Excalibur Awards. , Interested companies have until August ... after which, Semi-Finalists will be selected by the Excalibur ... required to meet with the judges for interviewing process. ...
(Date:7/30/2014)... 30, 2014 The American Telemedicine ... Sens. Thad Cochran (R-MS) and Roger Wicker (R-MS) ... telemedicine coverage under Medicare, Medicaid and Federal Communications ... Mississippi Republicans, introduced the Telehealth Enhancement Act as ... version, H.R. 3306, introduced by Rep. Gregg Harper ...
(Date:7/30/2014)... 2014 2014 Deep Research ... is a professional and in-depth research report ... provides basic Chitosan information, including Chitosan definition, ... well as industry overview. This research covers ... as well as global industry analysis covering ...
Breaking Medicine News(10 mins):Health News:Biologists describe mechanism promoting multiple DNA mutations 2Health News:Gene Mutation May Make Food More Tempting 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 3Health News:ATA Applauds Senators’ Push for Federal Telemedicine Improvements 2Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 2Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 3Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 4
... 14 ECRI Institute Patient Safety Organization (PSO) ... Coalition for Quality & Patient Safety (CQPS) of ... reporting, and analysis. The Chicagoland PSO focuses on ... specific to Chicago and the surrounding counties. CQPS ...
... 14 May 2009 Research4Life today announces that ... (OARE) program has registered 1500 institutions since its ... percent. This means that scientists, researchers and environmental ... poorest countries can gain free or low cost ...
... Anpath Group, Inc. (OTC Bulleting Board: ANPG), ... (ESI) and its distributor partner, Minntech Japan Corporation, ... 36th annual meeting of the Japanese Society of ... meeting was attended by over 4,000 medical professionals. ...
... Research Month activities include spring dedication at the ... Today Intergraph(R) and the Huntsville Botanical Garden once ... at the Intergraph Garden of Hope spring dedication. ... from the Huntsville community convened to celebrate life ...
... Stem for Life FoundationNEW YORK, May 14 NeoStem, Inc. ... pre-disease collection, processing and long-term storage of adult stem cells ... agreement for Ceres Living, Inc., a developer and direct marketer ... of an innovative nutritional supplement - AIO Premium Cellular Health. ...
... GABLES, Fla., May 14 Catalyst Pharmaceutical Partners, Inc. (Nasdaq: ... first quarter ended March 31, 2009. First Quarter ... the Company reported a net loss of $3,031,201, or $0.22 ... of $1,584,047, or $0.13 per basic and diluted share, for ...
Cached Medicine News:Health News:Coalition for Quality & Patient Safety of Chicagoland PSO Taps ECRI Institute PSO for Patient Safety Support 2Health News:Coalition for Quality & Patient Safety of Chicagoland PSO Taps ECRI Institute PSO for Patient Safety Support 3Health News:Coalition for Quality & Patient Safety of Chicagoland PSO Taps ECRI Institute PSO for Patient Safety Support 4Health News:Coalition for Quality & Patient Safety of Chicagoland PSO Taps ECRI Institute PSO for Patient Safety Support 5Health News:Access to environmental research in developing nations grown to 1,500 institutions 2Health News:Anpath Group, Inc. Distributor Introduces Products at the Japanese Society of Intensive Care Medicine Annual Meeting 2Health News:Courageous Cancer Survivors Honored at Intergraph(R) Garden of Hope 2Health News:Courageous Cancer Survivors Honored at Intergraph(R) Garden of Hope 3Health News:Courageous Cancer Survivors Honored at Intergraph(R) Garden of Hope 4Health News:Courageous Cancer Survivors Honored at Intergraph(R) Garden of Hope 5Health News:Courageous Cancer Survivors Honored at Intergraph(R) Garden of Hope 6Health News:Courageous Cancer Survivors Honored at Intergraph(R) Garden of Hope 7Health News:NeoStem Signs Agreement for Ceres Living, Inc. to Market Innovative Nutritional Supplement Designed to Optimize Stem Cell Functions 2Health News:NeoStem Signs Agreement for Ceres Living, Inc. to Market Innovative Nutritional Supplement Designed to Optimize Stem Cell Functions 3Health News:Catalyst Pharmaceutical Partners Reports First Quarter 2009 Financial Results 2Health News:Catalyst Pharmaceutical Partners Reports First Quarter 2009 Financial Results 3Health News:Catalyst Pharmaceutical Partners Reports First Quarter 2009 Financial Results 4Health News:Catalyst Pharmaceutical Partners Reports First Quarter 2009 Financial Results 5
(Date:7/30/2014)... 30, 2014 /PRNewswire-iReach/ -- Transluminal Technologies LLC, a ... company, has announced today that they have received ... Closure Device. Velox CD™ provides a safe and ... femoral procedures. The single size velox CD™ is ... from 5F to 8F.  Velox CD™ ...
(Date:7/30/2014)... , July 30, 2014  InnoPharma, Inc. today announced ... (the generic equivalent of Zyprexa® injection), in Canada.  Olanzapine ... disturbed behaviors in patients with schizophrenia or bipolar I ... injectable drug, InnoPharma has entered into an agreement with ... will make, use, sell, market and distribute Olanzapine ...
(Date:7/30/2014)... , July 30, 2014  Regeneron Pharmaceuticals, Inc. ... and NYSE: SNY ) today announced that ... people with hypercholesterolemia met their primary efficacy endpoint of ... cholesterol (LDL-C) at 24 weeks compared to placebo or ... PCSK9 (proprotein convertase subtilisin/kexin type 9). In ...
Breaking Medicine Technology:Transluminal Technologies receives CE Mark approval for velox CD(TM) vascular closure device 2InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8
... New data being presented at the American College ... San Diego showed that treatment with KAPIDEX(TM) (dexlansoprazole) ... in a statistically significant greater percentage of nights ... disease (GERD), compared to placebo (p<0.001). In addition, ...
... SAN DIEGO, Oct. 26 Volcano Corporation (Nasdaq: VOLC ... products for the diagnosis and treatment of coronary and peripheral ... results for the third quarter and first nine months of ... hold a conference call to discuss its financial results and ...
Cached Medicine Technology:New Study Results Analyzed the Use of KAPIDEX(TM) (dexlansoprazole) for Nighttime Heartburn in Adults with Non-Erosive GERD 2New Study Results Analyzed the Use of KAPIDEX(TM) (dexlansoprazole) for Nighttime Heartburn in Adults with Non-Erosive GERD 3Volcano Corporation Schedules Third Quarter Conference Call, Webcast 2
... The new SureCut M3500 Radial Microtome has ... is marvelous, and a range of functions and ... users. Based on years of experience and ... innovative design the SureCut M3500 Microtome will be ...
Spare fuse set...
Clock oil, 6 grams net...
Honing compound for knife sharpening, 6 grams net...
Medicine Products: